News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,375 Results
Type
Article (41548)
Company Profile (98)
Press Release (552729)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (162408)
Career Advice (2442)
Deals (29662)
Drug Delivery (104)
Drug Development (73682)
Employer Resources (146)
FDA (14402)
Job Trends (13261)
News (286154)
Policy (28376)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (2627)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (79)
Alliances (41615)
ALS (90)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (121)
Approvals (14393)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (15)
Bankruptcy (319)
Best Places to Work (10887)
BIOSECURE Act (16)
Biosimilars (107)
Biotechnology (70)
Bladder cancer (62)
Brain cancer (26)
Breast cancer (250)
Cancer (2001)
Cardiovascular disease (177)
Career advice (2053)
Career pathing (31)
CAR-T (135)
Cell therapy (379)
Cervical cancer (17)
Clinical research (59954)
Collaboration (720)
Compensation (268)
Complete response letters (23)
COVID-19 (2538)
CRISPR (40)
C-suite (236)
Cystic fibrosis (86)
Data (1979)
Decentralized trials (2)
Denatured (14)
Depression (47)
Diabetes (251)
Diagnostics (6189)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (118)
Drug pricing (102)
Drug shortages (23)
Duchenne muscular dystrophy (93)
Earnings (58060)
Editorial (38)
Employer branding (19)
Employer resources (132)
Events (97410)
Executive appointments (691)
FDA (15514)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (671)
Gene editing (99)
Generative AI (26)
Gene therapy (284)
GLP-1 (701)
Government (4321)
Grass and pollen (4)
Guidances (48)
Healthcare (18094)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (122)
Indications (26)
Infectious disease (2683)
Inflammatory bowel disease (126)
Inflation Reduction Act (10)
Influenza (52)
Intellectual property (82)
Interviews (522)
IPO (13272)
IRA (44)
Job creations (2797)
Job search strategy (1684)
Kidney cancer (10)
Labor market (17)
Layoffs (422)
Leadership (20)
Legal (6156)
Liver cancer (71)
Lung cancer (305)
Lymphoma (131)
Machine learning (5)
Management (53)
Manufacturing (239)
MASH (69)
Medical device (12023)
Medtech (12027)
Mergers & acquisitions (16876)
Metabolic disorders (655)
Multiple sclerosis (72)
NASH (23)
Neurodegenerative disease (94)
Neuropsychiatric disorders (29)
Neuroscience (1913)
NextGen: Class of 2025 (6186)
Non-profit (4235)
Northern California (2259)
Now hiring (29)
Obesity (343)
Opinion (219)
Ovarian cancer (72)
Pain (82)
Pancreatic cancer (77)
Parkinson's disease (143)
Partnered (17)
Patents (203)
Patient recruitment (94)
Peanut (45)
People (53346)
Pharmaceutical (29)
Pharmacy benefit managers (14)
Phase I (18418)
Phase II (26337)
Phase III (20200)
Pipeline (1091)
Policy (124)
Postmarket research (2360)
Preclinical (7459)
Press Release (55)
Prostate cancer (93)
Psychedelics (37)
Radiopharmaceuticals (231)
Rare diseases (365)
Real estate (4516)
Recruiting (58)
Regulatory (19869)
Reports (25)
Research institute (2229)
Resumes & cover letters (357)
Rett syndrome (4)
RNA editing (3)
RSV (40)
Schizophrenia (72)
Series A (120)
Series B (79)
Service/supplier (4)
Sickle cell disease (56)
Southern California (1993)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (27)
Startups (3002)
State (2)
Stomach cancer (14)
Supply chain (55)
Tariffs (16)
The Weekly (44)
United States (19842)
Vaccines (637)
Venture capitalists (33)
Weight loss (233)
Women's health (29)
Worklife (17)
Date
Today (98)
Last 7 days (430)
Last 30 days (2353)
Last 365 days (31007)
2025 (8515)
2024 (32900)
2023 (36921)
2022 (47646)
2021 (51728)
2020 (50403)
2019 (43652)
2018 (32932)
2017 (28794)
2016 (28040)
2015 (32944)
2014 (25117)
2013 (20522)
2012 (21816)
2011 (22737)
2010 (20106)
Location
Africa (771)
Alabama (50)
Alaska (4)
Arizona (163)
Arkansas (12)
Asia (35491)
Australia (7128)
California (5144)
Canada (1815)
China (455)
Colorado (235)
Connecticut (228)
Delaware (125)
Europe (80163)
Florida (797)
Georgia (195)
Hawaii (1)
Idaho (52)
Illinois (485)
India (23)
Indiana (286)
Iowa (5)
Japan (143)
Kansas (87)
Kentucky (21)
Louisiana (10)
Maine (59)
Maryland (793)
Massachusetts (3799)
Michigan (218)
Minnesota (327)
Mississippi (2)
Missouri (85)
Montana (22)
Nebraska (23)
Nevada (53)
New Hampshire (64)
New Jersey (1528)
New Mexico (22)
New York (1497)
North Carolina (853)
North Dakota (6)
Northern California (2259)
Ohio (177)
Oklahoma (9)
Oregon (26)
Pennsylvania (1189)
Puerto Rico (12)
Rhode Island (25)
South America (1042)
South Carolina (18)
South Dakota (1)
Southern California (1993)
Tennessee (91)
Texas (772)
Utah (170)
Virginia (131)
Washington D.C. (58)
Washington State (489)
West Virginia (3)
Wisconsin (46)
594,375 Results for "celltrion healthcare formerly known as celltrion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion’s biosimilar to Humira® (adalimumab)
April 15, 2025
·
17 min read
Press Releases
Celltrion’s Infliximab, the First Monoclonal Antibody Biosimilar, Is Now Remdantry™ in Canada
March 12, 2025
·
5 min read
Press Releases
Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab)
February 24, 2025
·
6 min read
Press Releases
U.S. FDA approves Celltrion’s OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
March 10, 2025
·
10 min read
Press Releases
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
February 18, 2025
·
8 min read
Press Releases
U.S. FDA approves Celltrion’s AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®
January 30, 2025
·
8 min read
Press Releases
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®
March 4, 2025
·
12 min read
Press Releases
Health Canada approves Celltrion’s Omlyclo™ (CT-P39), the first and only omalizumab biosimilar in Canada
December 9, 2024
·
3 min read
Press Releases
Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
January 15, 2025
·
5 min read
1 of 59,438
Next
